|Articles|November 17, 2011
Lovaza Manufacturer to Enter Consumer Healthcare Market
Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012.
Advertisement
Answering to rising consumer interest in omega-3 products, Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012. The company currently markets Omacor/Lovaza, the only omega-3 pharmaceutical drug approved for use by FDA and the EU.
Over the next 12 months, Pronova plans to build its consumer healthcare division by initiating clinical trials, adjusting manufacturing its manufacturing process for consumer products, and developing distribution channels.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
3
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
4
Lion’s Mane Ingredient Targets Standardized Erinacine A
5